0001628738-14-000002.txt : 20141224 0001628738-14-000002.hdr.sgml : 20141224 20141223205125 ACCESSION NUMBER: 0001628738-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141224 DATE AS OF CHANGE: 20141223 EFFECTIVENESS DATE: 20141224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Audentes Therapeutics, Inc. CENTRAL INDEX KEY: 0001628738 IRS NUMBER: 461606174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-230835 FILM NUMBER: 141308352 BUSINESS ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-638-6556 MAIL ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 D 1 primary_doc.xml X0707 D LIVE 0001628738 Audentes Therapeutics, Inc. 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA CALIFORNIA 94104 415-638-6556 DELAWARE None None Corporation true 2012 Matthew Patterson 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Executive Officer Director Jonathan SIlverstein 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Director Kush Parmar 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Director Thomas Woiwode 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Director Thomas Schuetz 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Director Jonathan Leff 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Director Biotechnology Decline to Disclose 06b false 2014-11-21 false true false 0 42500002 42500002 0 false 11 0 0 0 false Audentes Therapeutics, Inc. Matthew Patterson Matthew Patterson President and CEO 2014-12-10